Morningstar Investor users sign in here.

Company Profile

  • Business description

    Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

  • Contact

    1220 Concord Avenue
    Suite 600
    Concord CA 94520
    USA

    T: +1 925 288-6000

    E: ir@cerus.com

    https://www.cerus.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2024

    Employees

    280

Cerus Corp News & Analysis

funds

No room on the ARK?

If performance turns for the worst, money that has been quick to come may be quicker yet to go, writes Morningstar's Ben Johnson.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,140.20 20.00 0.25%
CAC 40 8,141.46 54.50 -0.66%
DAX 40 18,726.76 42.20 -0.22%
Dow JONES (US) 39,872.99 66.22 0.17%
FTSE 100 8,416.45 7.75 -0.09%
HKSE 19,220.62 415.60 -2.12%
NASDAQ 16,832.62 37.75 0.22%
Nikkei 225 38,735.21 211.72 -0.54%
NZX 50 Index 11,747.53 71.54 0.61%
S&P 500 5,321.41 13.28 0.25%
S&P/ASX 200 7,869.60 17.90 0.23%
SSE Composite Index 3,157.59 0.38 -0.01%

Market Movers

Name
Last price
Change
% Change
Telstra Group Ltd TLS 3.44 0.13 -3.64%
Sayona Mining Ltd SYA 0.04 0.00 0.00%
Resolute Mining Ltd RSG 0.54 0.04 7.43%
Strike Energy Ltd STX 0.21 0.00 1.19%
Peninsula Energy Ltd PEN 0.12 0.00 2.17%
Pilbara Minerals Ltd PLS 4.10 0.06 -1.33%
Alumina Ltd AWC 1.83 0.09 4.89%
Imugene Ltd IMU 0.07 0.00 2.17%
South32 Ltd S32 3.90 0.00 0.00%
Melbana Energy Ltd MAY 0.05 0.00 8.51%